These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2284378)
21. [Toxic tricyclic drug plasma level caused by fluoxetine]. Hambrecht M Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758 [TBL] [Abstract][Full Text] [Related]
22. [Psychosocial adjustment of unipolar and bipolar patients]. Escande M; Gavarret P; Charlet JP Encephale; 1995 Dec; 21 Spec No 4():55-9. PubMed ID: 8808348 [No Abstract] [Full Text] [Related]
23. [Bipolar disorders--how to recognize and treat them]. Grunze H; Sasse J; Forsthoff A; Bauer M MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694 [TBL] [Abstract][Full Text] [Related]
24. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy. Benazzi F J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383 [No Abstract] [Full Text] [Related]
25. [Biological treatment of acute depressive episodes]. Schmauss M; Messer T Fortschr Neurol Psychiatr; 2007 Oct; 75(10):617-27; quiz 628-30. PubMed ID: 17914677 [No Abstract] [Full Text] [Related]
26. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine. Bauer M; Linden M; Schaaf B; Weber HJ J Clin Psychopharmacol; 1996 Apr; 16(2):130-4. PubMed ID: 8690828 [TBL] [Abstract][Full Text] [Related]
27. International consensus group on depression prevention in bipolar disorder. Frye MA; Ha K; Kanba S; Kato T; McElroy SL; Özerdem A; Vázquez G; Vieta E J Clin Psychiatry; 2011 Oct; 72(10):1295-310. PubMed ID: 22075097 [No Abstract] [Full Text] [Related]
29. [Personality disorders and use of antidepressants]. Brochier T Encephale; 1994 Jun; 20 Spec No 2():267-8. PubMed ID: 8088244 [No Abstract] [Full Text] [Related]
30. What is the best approach to management of acute depression in bipolar disorder? Joffe RT; MacQueen GM; Young LT J Psychiatry Neurosci; 2000 Nov; 25(5):516. PubMed ID: 11109302 [No Abstract] [Full Text] [Related]
35. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond. Vieta E J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719 [No Abstract] [Full Text] [Related]
36. Upping the ante on antidepressants. Malhi GS Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513 [No Abstract] [Full Text] [Related]
37. Use of atypical antipsychotics in refractory depression and anxiety. Nemeroff CB J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032 [TBL] [Abstract][Full Text] [Related]
38. Suicidality and fluoxetine revisited. Masand P; Dewan M J Clin Psychiatry; 1992 Mar; 53(3):102-3. PubMed ID: 1548246 [No Abstract] [Full Text] [Related]
39. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. Austin LS; Arana GW; Melvin JA J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160 [TBL] [Abstract][Full Text] [Related]
40. [Combination of various antidepressive drugs in treatment of therapy refractory depression]. Bauer M; Linden M Nervenarzt; 1993 May; 64(5):343-7. PubMed ID: 8321345 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]